Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam;Coûts d'administration du vaccin contre le papillomavirus humain chez les jeunes adolescentes au Pérou, en Ouganda et au Viet Nam

Bulletin of the World Health Organization

Volumn 91, Issue 8, 2013, Pages 585-592

  Levin, Carol E ^a   Van Minh, Hoang ^b   Odaga, John ^c   Rout, Swampa Sarit ^d   Ngoc, Diep Nguyen Thi ^e   Menezes, Lysander ^f   Araujo, Maria Ana Mendoza ^g   Lamontagneh, D Scott ^h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c MAKERERE UNIVERSITY   (Uganda)

^d Centre for Operations Research and Training   (India)

^e PATH   (Viet Nam)

^f PATH   (India)

^g MINISTERIO DE SALUD   (Peru)

^h PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENCE; HEALTH CARE; HEALTH SERVICES; IMMUNIZATION; VACCINATION; VACCINE; YOUNG POPULATION;

ADOLESCENT; ARTICLE; DOCUMENTATION; DRUG COST; FEMALE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH CENTER; HEALTH SERVICE; HUMAN; HUMAN PAPILLOMAVIRUS VACCINATION; INFORMATION PROCESSING; PERU; PREVENTIVE HEALTH SERVICE; SCHOOL; UGANDA; VACCINATION; VIET NAM;

PERU; UGANDA; UNITED STATES; VIET NAM;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; BUDGETS; COSTS AND COST ANALYSIS; DRUG COSTS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS VACCINES; PERU; PILOT PROJECTS; UGANDA; VIETNAM;

EID: 84880969700     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.113837     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. doi: http://dx.doi.org/10.1002/ijc.25516 PMID:21351269
2. World Health Organization [Internet]. Immunization, vaccines and biologicals. Human papillomavirus (HPV). Geneva: World Health Organization. Available from: http://www.who.int/immunization/topics/hpv/en/ [accessed 16 June 2013].
3. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries. Vaccine 2008;26:4080-93. doi: http://dx.doi.org/10.1016/j.vaccine.2008.04.053 PMID:18550229
4. Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 2009;27:127-47. doi: http://dx.doi.org/10.2165/00019053-200927020-00004 PMID:19254046
5. Bingham A, Janmohamed A, Bartolini R, Creed-Kanashiro H, Katahoire A, Khan I et al. An approach to formative research in HPV vaccine introduction planning in low-resource settings. Open Vaccine J 2009;2:1-16. doi: http://dx.doi.org/10.2174/1875035400902010001
6. Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 2008;12:159-72. PMID:19435020
7. Bartolini RM, Drake JK, Creed-Kanashiro HM, Díaz-Otoya MM, Mosqueira-Lovón NR, Penny ME et al. Investigación formativa para diseñar estrategias para la introducción de la vacuna contra el VPH en el Perú. [Formative research to shape HPV vaccine introduction strategies in Peru]. Salud Publica Mex 2010;52:226-33. Spanish doi: http://dx.doi.org/http://dx.10.1590/S0036-36342010000300007
8. Nghi NQ, Lamontagne DS, Bingham A, Rafiq M, Mai TP, Lien N et al. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health 2010;7:262-70. doi: http://dx.doi.org/10.1071/SH09123 PMID:20719213
9. Jacob M, Mawar N, Menezes L, Kaipilyawar S, Gandhi S, Khan I et al. Assessing the environment for introduction of human papillomavirus vaccine in India. Open Vaccine J 2010;3:96-107. doi: http://dx.doi.org/10.2174/1875035401003010096
10. Biellik R, Levin C, Mugisha E, LaMontagne DS, Bingham A, Kaipilyawar S et al. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine 2009;27:6203-9. doi: http://dx.doi.org/10.1016/j.vaccine.2009.08.003 PMID:19698808
11. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011;89:821-830B.
12. Penny M, Bartolini R, Mosqueira NR, LaMontagne DS, Mendoza MA, Ramos I et al. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine 2011;29:5022-30. doi: http://dx.doi.org/10.1016/j.vaccine.2011.04.078 PMID:21609748
13. Bartolini RM, Winkler JL, Penny ME, LaMontagne DS. Parental acceptance of HPV vaccine in Peru: a decision framework. PLoS One 2012;7:e48017. doi: http://dx.doi.org/10.1371/journal.pone.0048017 PMID:23144719
14. Cover JK, Nghi NQ, LaMontagne DS, Huyen DT, Hien NT, Nga T. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health 2012;12:629. doi: http://dx.doi.org/10.1186/1471-2458-12-629 PMID:22877158
15. PATH, National Institute of Hygiene and Epidemiology & National Center for Health Education and Communication. HPV vaccination in Southeast Asia: lessons learned from a pilot program in Vietnam. Seattle: PATH; 2012. Available from: http://www.rho.org/files/rb4/HPV_lessons_learned_Vietnam_PATH_2012.pdf [accessed 16 June 2013].
16. Katahoire AR, Murokora D, Arube-Wani J, Mugisha E, LaMontagne DS. Acceptability of HPV vaccine among young adolescent girls in Uganda: young people's perspectives count. Intl J Child Adolesc Health 2013. 6. In press.
17. PATH, Child Health and Development Centre & Uganda National Expanded Program on Immunization. HPV vaccination in Africa: lessons learned from a pilot program in Uganda. Seattle: PATH; 2011. Available from: http://www.rho.org/files/rb2/HPV_lessons_learned_Uganda_PATH_2011.pdf [accessed 16 June 2013].
18. HPV vaccine adoption in developing countries: cost and financing issues. New York & Seattle: International AIDS Vaccine Initiative & PATH; 2007.
19. Temin M, Levin R. Start with a girl: a new agenda for global health. Washington: Center for Global Development; 2009. Available from: www.cgdev.org/files/1422899_file_Start_with_a_Girl_FINAL.pdf [accessed 7 June 2013].
20. Guidelines for estimating costs of introducing new vaccines into the national immunization system. Geneva: World Health Organization; 2002 (WHO/V&B/02.11).
21. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries. Geneva: World Health Organization; 2006.
22. The World Bank [Internet]. Consumer price index (2005 = 100). Washington: The World Bank; 2012. Available from: http://data.worldbank.org/indicator/FP.CPI.TOTL [accessed 7 June 2013].
23. Pan American Health Organization. PAHO Revolving Fund: vaccine and syringe prices, 2011. Immunization Newsletter 2011;XXXIII:5.
24. Co-financing new vaccines and sustainability: meeting report of the Africa Region workshop. New York: United Nations Children's Fund; 2009.
25. GAVI Alliance [Internet]. Co-financing policy. Geneva: GAVI Alliance; 2010. Available from: www.gavialliance.org/about/governance/programme-policies/co-financing [accessed 7 June 2013].
26. Operating procedures of the PAHO Revolving Fund for the purchase of vaccines, syringes and other related supplies. Washington: Pan American Health Organization; 2008.
27. Acharya A, Diaz-Ortega JL, Tambini G, de Quadros C, Arita I. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis. Vaccine 2002;20:3332-41. doi: http://dx.doi.org/10.1016/S0264-410X(02)00296-7 PMID:12213403
28. Walker D, Mosqueira NR, Penny ME, Lanata CF, Clark AD, Sanderson CF et al. Variation in the costs of delivering routine immunization services in Peru. Bull World Health Organ 2004;82:676-82. PMID:15628205
29. Griffiths UK, Wolfson LJ, Quddus A, Younus M, Hafiz RA. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Bull World Health Organ 2004;82:643-51. PMID:15628201
30. Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P. Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Vaccine 2004;22:475-84. doi: http://dx.doi.org/10.1016/j.vaccine.2003.07.007 PMID:14670330
31. Hoang MV, Nguyen TB, Kim BG, Dao LH, Nguyen TH, Wright P. Cost of providing the expanded programme on immunization: findings from a facility-based study in Viet Nam, 2005. Bull World Health Organ 2008;86:429-34. doi: http://dx.doi.org/10.2471/BLT.07.045161 PMID:18568271
32. Brenzel L, Wolfson LJ, Fox-Rusby J, Miller M, Halsey NA. Vaccine preventable diseases. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington: The World Bank; 2006.
33. Galagan SR, Paul P, Menezes L, LaMontagne DS. Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine 2013. Epub May 15
34. Griffiths UK, Korczak VS, Ayalew D, Yigzaw A. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine 2009;27:1426-32. doi: http://dx.doi.org/10.1016/j.vaccine.2008.12.037 PMID:19146901
35. Touch S, Suraratdecha C, Samnang C, Heng S, Gazley L, Huch C et al. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia. Vaccine 2010;28:4593-9. doi: http://dx.doi.org/10.1016/j.vaccine.2010.04.086 PMID:20470803
36. Perú, Ministerio de Economía y Finanzas [Internet]. Presupuesto público. Lima: MEF; 2013. Available from: www.mef.gob.pe [accessed 7 June 2013].
37. Ministerio de Salud [Internet]. Llega al Perú primer lote de vacunas contra el cáncer de cuello uterino. [The first batch of cervical cancer vaccines arrives in Peru]. Lima: Ministerio de Salud; 2011. Spanish. Available from: http://www.minsa.gob.pe/portada/prensa/notas_auxiliar.asp?nota=9896 [accessed 7 June 2013].
38. GAVI Alliance [Internet]. Human papillomavirus vaccine support. Geneva: GAVI; 2013. Available from: http://www.gavialliance.org/support/nvs/human-papillomavirus-vaccine-support/ [accessed 16 June 2013]
39. Okino P. First Lady launches cervical cancer fight. Kampala: New Vision 7 September 2012. Available from: http://www.newvision.co.ug/news/635003-first-lady-launches-cervical-cancer-vaccination-drive.html [accessed 7 June 2013]